Stay updated on Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page.

Latest updates to the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page
- Check6 days agoChange DetectedNo significant changes detected in the study details or site listings. The information presented remains consistent with the page’s purpose and does not affect enrollment or understanding.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check35 days agoChange DetectedAdded a government funding notice and current operating status guidance (and updated the version to v3.2.0), replacing the previous v3.1.0.SummaryDifference0.9%

- Check42 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not alter core content or other critical info.SummaryDifference0.0%

- Check56 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; Back to Top element removed. No substantive content changes.SummaryDifference0.1%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%

- Check70 days agoChange DetectedThe webpage has been updated to include new facility names and locations, as well as additional drug information related to avelumab and axitinib. Notably, the total number of study locations has been revised from 272 to 270.SummaryDifference21%

Stay in the know with updates to Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page.